Authors

• Simone Møller Hede (ORCID: https://orcid.org/0000-0003-2074-7921)
• Alexis A. Krumme (ORCID: https://orcid.org/0000-0001-9633-861X)
• Suzan Esslinger (ORCID: https://orcid.org/0000-0003-1052-058X)
• Erik Hertervig
• Cindy Weinstein (ORCID: https://orcid.org/0000-0003-4229-4644)
• Stine Kloster (ORCID: https://orcid.org/0000-0002-6142-8305)
• Frida Richter Hansen (ORCID: https://orcid.org/0000-0002-4729-2683)
• Zhiping Huang (ORCID: https://orcid.org/0000-0003-1262-3697)
• Annette Kjær Ersbøll (ORCID: https://orcid.org/0000-0002-9407-3387)
• James D. Lewis (ORCID: https://orcid.org/0000-0003-3107-3862)
• Kristian Bolin (ORCID: https://orcid.org/0000-0003-1682-295X)
• Lau Caspar Thygesen (ORCID: https://orcid.org/0000-0001-8375-5211)
• Thora Majlund Kjærulff (ORCID: https://orcid.org/0000-0002-3314-6570)
• Vibeke Andersen (ORCID: https://orcid.org/0000-0002-0127-2863)
• Deanna Hill
• Niels Qvist (ORCID: https://orcid.org/0000-0002-1113-195X)
• Marie Skov Kristensen (ORCID: https://orcid.org/0000-0002-8066-8937)
• Anders Green (ORCID: https://orcid.org/0000-0002-5059-3655)
• Laila Mehkri
• Lila Kallio

Institutions

• University of Copenhagen (DK)
• Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
• Steno Diabetes Centers (DK)
• University of Turku (FI)
• University of Southern Denmark (DK)
• Frederiksberg Hospital (DK)
• Odense University Hospital (DK)
• Turku University Hospital (FI)
• Center for Clinical Research and Prevention (DK)
• Skåne University Hospital (SE)
• Janssen (United States) (US)
• University of Pennsylvania (US)
• University of Gothenburg (SE)

Publication Details

Journal

Drug Safety

Published

2025-02-06

DOI

https://doi.org/10.1007/s40264-025-01519-8

Citations

1

Primary Topic

Inflammatory Bowel Disease

Type

article

Field-Weighted Citation Impact

1.82

Funders

• Merck
• Syddansk Universitet